Lumefantrine
An antimalarial drug used in combination therapies
| Lumefantrine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Lumefantrine is an antimalarial drug used in combination with artemether to treat malaria. It is part of the artemisinin-based combination therapies (ACTs) recommended by the World Health Organization for the treatment of uncomplicated Plasmodium falciparum malaria.
Pharmacology[edit | edit source]
Lumefantrine is a lipophilic compound that is poorly soluble in water. It is absorbed in the gastrointestinal tract and is metabolized in the liver by the cytochrome P450 system, primarily by the enzyme CYP3A4. The drug has a long half-life, which helps in maintaining therapeutic levels in the blood for an extended period, thus aiding in the prevention of malaria recurrence.
Mechanism of Action[edit | edit source]
Lumefantrine works by interfering with the haem polymerization process in the Plasmodium parasites. This process is crucial for the parasite's survival as it detoxifies the free haem released during the digestion of hemoglobin. By inhibiting this process, lumefantrine causes the accumulation of toxic haem, leading to the death of the parasite.
Clinical Use[edit | edit source]
Lumefantrine is used in combination with artemether, marketed under the brand name Coartem. This combination is effective against chloroquine-resistant strains of Plasmodium falciparum. The combination therapy is administered orally and is typically given over a three-day course.
Side Effects[edit | edit source]
Common side effects of lumefantrine include headache, dizziness, anorexia, and nausea. Serious side effects are rare but may include allergic reactions and QT interval prolongation, which can lead to arrhythmias.
History[edit | edit source]
Lumefantrine was developed in the 1980s and was initially used in China. It gained international recognition after being included in the World Health Organization's List of Essential Medicines. The combination with artemether was developed to enhance efficacy and reduce the risk of resistance.
Related pages[edit | edit source]
Lumefantrine
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
